Atai Life Sciences Stock (NASDAQ:ATAI)


Today's Range
$10.29 - $11.32
52-Week Range
$10.29 - $22.91
Market Cap

About Atai Life Sciences (NASDAQ:ATAI)


Atai Life Sciences N.V. focuses on operating as a holding company for ATAI Life Sciences AG that operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that are focused on multiple mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment of treatment-resistant depression (TRD); RL-007, a GABA/nicotinic modulator to treat cognitive impairment associated with schizophrenia; DMX-1002, an oral formulation of ibogaine for treating opioid use disorder (OUD); GRX-917, an oral formulation of a deuterated version of etifoxine for the generalized anxiety disorder treatment; and NN-101, a novel intranasal formulation of N-acetylcysteine to treat mild traumatic brain injuries. Its therapeutic candidates also comprise VLS-01 is a formulation of N,N-dimethyltryptamine for treating TRD; EMP-01, an oral formulation of an 3,4-methyl enedioxy methamphetamine for the treatment of post-traumatic stress disorder; RLS-01, a formulation of Salvinorin A for TRD; KUR-101, an oral formulation of deuterated mitragynine to treat OUD; and DMX-1001, an oral formulation of noribogaine for the treatment of OUD. The company was formerly known as Adripa Holding B.V. Atai Life Sciences N.V. was founded in 2018 and is headquartered in Berlin, Germany.

Show more

ATAI Stock Price

Statistics Highlights (NASDAQ:ATAI)

Shares Outstanding 160.30M Beta -
Public Float 127.26M P/E Ratio -
% Short of Float - Dividend (Yield) -
Held by Insiders 9.22% Ex-Dividend Date
Held by Institutions 25.69% IPO Date Jun 18, 2021

ATAI Financial Summary

Dec 20 Dec 19
Revenue $0.00 $0.00
EBITDA $-103.78M $-17.84M
Net Income $-169.84M $-14.14M
Total Assets $111.55M $62.12M
Total Cash $97.25M $30.06M
Total Debt $2.18M $157.00K
Sep 21 Jun 21 Mar 21
Revenue $266.00K $0.00 $19.88M
EBITDA $-30.80M $-55.84M $700.00K
Net Income $-31.16M $-48.46M $688.00K
Total Assets $484.11M $505.96M $145.26M
Total Cash $430.31M $453.62M $104.37M
Total Debt $838.00K $1.22M $2.96M

(NASDAQ:ATAI) Stock Price FAQs

What is today's stock price of Atai Life Sciences (NASDAQ:ATAI)?

  • The current stock price of Atai Life Sciences (NASDAQ:ATAI) is $10.58.
  • Today ATAI stock price opened at $11.14 after previous close of $11.14.
  • During the day, Atai Life Sciences stock quote has varied from a low of $10.29 to a high of $11.32.

What is Atai Life Sciences's 52-week change?

  • ATAI 52-week high stock quote is $22.91, which is 116.50% above the current share price.
  • The Atai Life Sciences (NASDAQ:ATAI) 52-week low stock price is $10.29, which is 2.70% below the current share price.

Atai Life Sciences (NASDAQ:ATAI) FAQ

How Much is Atai life sciences Worth?

Atai life sciences's worth today based on market capitalisation is $1.76B

How much money does Atai life sciences make?

Last quarter (ended on September 30 ,2021) Atai life sciences generated a net income of $-31.16M, representing a 167.01% increase compared to the same quarter a year before (ended on September 30 ,2020).
Last fiscal year (ended on December 31 ,2020) Atai life sciences generated a net income of $-169.84M, representing a 1101.32% increase compare to the previous fiscal year (ended on December 31 ,2019).
View More Details on Atai life sciences's “Financials” Section

How much dividend does Atai life sciences Pay?

The current annualized dividend payout for ATAI stock is $0.00, the dividend yield is 0.00% and the payout ratio is 0.00%.
View More Details on Atai life sciences's "Dividend" Section

What were Atai life sciences’s last Earnings results?

For the last quarterly earnings period (ended on September 30, 2021) ATAI reported $-0.21 EPS for the quarter, beating the average analysts’ forecasts of $-0.22 EPS by $0.01 (6.54%).
View More Details on Atai life sciences's 'Earnings' Section

What is Atai life sciences’s Price to Earning (PE) ratio?

ATAI stock also has a Price to Sales (P/S) ratio of 84.18.

What is the Atai life sciences's ticker?

Atai life sciences trades on the NASDAQ stock market in USA under the ticker symbol "ATAI". Atai life sciences’s stock symbol can also be displayed as "NASDAQ:ATAI".

When did ATAI go public?

Atai life sciences completed its initial public offering (IPO) on June 18 ,2021.

Who are the owners of Atai life sciences?

Atai life sciences (NASDAQ:ATAI) is owned by 25.69% institutional shareholders and by 9.22% insiders. The rest is owned by the public.
Explore More Details on Atai life sciences's “Ownership” Section

Who are the key executives of Atai life sciences (ATAI)?

Atai life sciences's key executive team includes the following managers:

  • Mr. Florian Brand, Co-Founder, MD & CEO (1987)
  • Dr. Srinivas G. Rao M.D., Ph.D., Co-Founder & Chief Scientific Officer (1969)
  • Mr. Gregory L. Weaver CPA, M.B.A., MD & CFO (1956)
  • Mr. Christian Angermayer, Founder & Chairman of the Supervisory Board (1978)
  • Mr. Lars Christian Wilde, Co-Founder (1986)
  • Mr. Roman Dahl, VP of Operations & Innovation (NA)
  • Ms. Madison Crawford, Sr. Mang. of Accounting (NA)
  • Mr. Ryan Barrett, VP of Corp. Devel. & Gen. Counsel (NA)
  • Ms. Camilla Dormer, VP of Communications (NA)
  • Mr. Josh Elliott, Mang. of Marketing (NA)

What is Atai life sciences’s Sector & Industry Classification?

Atai life sciences (NASDAQ:ATAI) is classified under the "Healthcare" sector and under the "Biotechnology" industry.

How many employees work for Atai life sciences?

Currently the number of employees working for Atai life sciences is 35.

Where are Atai life sciences's Headquarters?

Atai life sciences (NASDAQ:ATAI) is headquartered in Germany.

What are Atai life sciences's Address and Phone Number?

Atai life sciences’s mailing address is Krausenstrasse 9-10, Berlin, Germany, 10117.
The company’s phone number is 49 89 2153 9035.

What is the official website for Atai life sciences?

Atai life sciences’s official website is